Adipose tissue-derived stem cell treatment prevents renal disease progression

Cell Transplantation

Volumn 21, Issue 8, 2012, Pages 1727-1741

  Donizetti Oliveira, Cassiano ^a   Semedo, Patricia ^a   Burgos Silva, Marina ^a   Cenedeze, Marco Antonio ^a   Malheiros, Denise Maria Avancini Costa ^b   Reis, Marlene A ^c   Pacheco Silva, Alvaro ^a   Câmara, Niels Olsen Saraiva ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

Acute kidney injury; Adipose derived stem cell; Fibrosis; Inflammation; Ischemia reperfusion injury

Indexed keywords

CALVASCULIN; COLLAGEN; COLLAGEN TYPE 1; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MESSENGER RNA; RANTES; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; VIMENTIN;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; HYPOXIA; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY SIZE; KIDNEY TUBULE; MOUSE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENAL PROTECTION; REPERFUSION INJURY; STEM CELL TRANSPLANTATION; TISSUE REGENERATION;

ADIPOSE TISSUE; ANIMALS; CHEMOKINE CCL5; CHEMOKINES; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HEME OXYGENASE-1; INTERLEUKIN-10; INTERLEUKIN-1ALPHA; INTERLEUKIN-4; INTERLEUKIN-6; ISCHEMIA; KIDNEY DISEASES; MALE; MICE; MICE, INBRED C57BL; RNA, MESSENGER; STEM CELL TRANSPLANTATION; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA; VIMENTIN;

ANIMALIA; MUS;

EID: 84864190119     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911X623925     Document Type: Article

References (65)

1. Aggarwal, S.; Pittenger, M. F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822; 2005.
2. Bachelder, R. E.; Yoon, S. O.; Franci, C.; de Herreros, A. G.; Mercurio, A. M. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: Implications for the epithelial-mesenchymal transition. J. Cell Biol. 168:29-33; 2005.
3. Bi, B.; Schmitt, R.; Israilova, M.; Nishio, H.; Cantley, L. G. Stromal cells protect against acute tubular injury via an endocrine effect. J. Am. Soc. Nephrol. 18:2486-2496; 2007.
4. Burne-Taney, M. J.; Yokota, N.; Rabb, H. Persistent renal and extrarenal immune changes after severe ischemic injury. Kidney Int. 67:1002-1009; 2005.
5. Camara, N. O.; Soares, M. P. Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction. Free Radic. Biol. Med. 38:426-435; 2005.
6. Chin, K.; Kurashima, Y.; Ogura, T.; Tajiri, H.; Yoshida, S.; Esumi, H. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene 15:437-442; 1997.
7. Choi, S.; Park, M.; Kim, J.; Hwang, S.; Park, S.; Lee, Y. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev. 18:521-529; 2009.
8. Devarajan, P. Update on mechanisms of ischemic acute kidney injury. J. Am. Soc. Nephrol. 17:1503-1520; 2006.
9. Dussaule, J. C.; Chatziantoniou, C. [Reversal of renal fibrosis: Lessons from experimental models]. Bull. Acad. Natl. Med. 192:987-1000; discussion 1000-1001; 2008.
10. Eddy, A. A. Molecular basis of renal fibrosis. Pediatr. Nephrol. 15:290-301; 2000.
11. Fang, B.; Song, Y.; Zhao, R. C.; Han, Q.; Lin, Q. Using human adipose tissue-derived mesenchymal stem cells as salvage therapy for hepatic graft-versus-host disease resembling acute hepatitis. Transplant. Proc. 39:1710-1713; 2007.
12. Feitoza, C. Q.; Goncalves, G. M.; Semedo, P.; Cenedeze, M. A.; Pinheiro, H. S.; Beraldo, F. C.; dos Santos, O. F.; Teixeira, V. de P.; dos Reis, M. A.; Mazzali, M.; Pacheco- Silva, A.; Câmara, N. O. S. Inhibition of COX 1 and 2 prior to renal ischemia/reperfusion injury decreases the development of fibrosis. Mol. Med. 14:724-730; 2008.
13. Gianella, A.; Nobili, E.; Abbate, M.; Zoja, C.; Gelosa, P.; Mussoni, L.; Bellosta, S.; Canavesi, M.; Rottoli, D.; Guerrini, U.; Brioschi, M.; Banfi, C.; Tremoli, E.; Remuzzi, G.; Sironi, L. Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats. Am. J. Pathol. 170:1165-1177; 2007.
14. Gimble, J. M.; Katz, A. J.; Bunnell, B. A. Adipose-derived stem cells for regenerative medicine. Circ. Res. 100: 1249-1260; 2007.
15. Goldberg, R.; Dennen, P. Long-term outcomes of acute kidney injury. Adv. Chronic Kidney Dis. 15:297-307; 2008.
16. Gonzalez, M. A.; Gonzalez-Rey, E.; Rico, L.; Buscher, D.; Delgado, M. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136:978-989; 2009.
17. Gonzalez, M. A.; Gonzalez-Rey, E.; Rico, L.; Buscher, D.; Delgado, M. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum. 60:1006-1019; 2009.
18. Gronthos, S.; Franklin, D. M.; Leddy, H. A.; Robey, P. G.; Storms, R. W.; Gimble, J. M. Surface protein characterization of human adipose tissue-derived stromal cells. J. Cell. Physiol. 189:54-63; 2001.
19. Guijarro, C.; Egido, J. Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int. 59:415-424; 2001.
20. Hill, G. S.; Delahousse, M.; Nochy, D.; Thervet, E.; Vrtovsnik, F.; Remy, P.; Glotz, D.; Bariety, J. Outcome of relapse in lupus nephritis: Roles of reversal of renal fibrosis and response of inflammation to therapy. Kidney Int. 61:2176-2186; 2002.
21. Huang, Y.; Rabb, H.; Womer, K. L. Ischemia-reperfusion and immediate T cell responses. Cell. Immunol. 248:4-11; 2007.
22. Ikeda, M.; Prachasilchai, W.; Burne-Taney, M. J.; Rabb, H.; Yokota-Ikeda, N. Ischemic acute tubular necrosis models and drug discovery: A focus on cellular inflammation. Drug Discov. Today 11:364-370; 2006.
23. Ivanova-Todorova, E.; Bochev, I.; Mourdjeva, M.; Dimitrov, R.; Bukarev, D.; Kyurkchiev, S.; Tivchev, P.; Altunkova, I.; Kyurkchiev, D. S. Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells. Immunol. Lett. 126:37-42; 2009.
24. Kalluri, R.; Weinberg, R. A. The basics of epithelial- mesenchymal transition. J. Clin. Invest. 119:1420-1428; 2009.
25. Kang, S. K.; Lee, D. H.; Bae, Y. C.; Kim, H. K.; Baik, S. Y.; Jung, J. S. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp. Neurol. 183:355-366; 2003.
26. Kie, J. H.; Kapturczak, M. H.; Traylor, A.; Agarwal, A.; Hill-Kapturczak, N. Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis. J. Am. Soc. Nephrol. 19:1681-1691; 2008.
27. Lange-Sperandio, B.; Trautmann, A.; Eickelberg, O.; Jayachandran, A.; Oberle, S.; Schmidutz, F.; Rodenbeck, B.; Homme, M.; Horuk, R.; Schaefer, F. Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice. Am. J. Pathol. 171:861-871; 2007.
28. Leask, A.; Abraham, D. J. TGF-beta signaling and the fibrotic response. FASEB J. 18:816-827; 2004.
29. Lechner, M.; Lirk, P.; Rieder, J. Inducible nitric oxide synthase (iNOS) in tumor biology: The two sides of the same coin. Sem. Cancer Biol. 15:277-289; 2005.
30. Levey, A. S.; Stevens, L. A.; Coresh, J. Conceptual model of CKD: Applications and implications. Am. J. Kidney Dis. 53:S4-S16; 2009.
31. Levy, E. M.; Viscoli, C. M.; Horwitz, R. I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275:1489-1494; 1996.
32. Liu, X. Inflammatory cytokines augments TGF-beta1- induced epithelial-mesenchymal transition in A549 cells by up-regulating TbetaR-I. Cell. Motil. Cytoskeleton 65:935-944; 2008.
33. Magnasco, A.; Corselli, M.; Bertelli, R.; Ibatici, A.; Peresi, M.; Gaggero, G.; Cappiello, V.; Chiavarina, B.; Mattioli, G.; Gusmano, R.; Ravetti, J. L.; Frassoni, F.; Ghiggeri, G. M. Mesenchymal stem cells protective effect in adriamycin model of nephropathy. Cell Transplant. 17:1157-1167; 2008.
34. Mehta, R. L.; Pascual, M. T.; Soroko, S.; Savage, B. R.; Himmelfarb, J.; Ikizler, T. A.; Paganini, E. P.; Chertow, G. M. Spectrum of acute renal failure in the intensive care unit: The PICARD experience. Kidney Int. 66:1613-1621; 2004.
35. Mitchell, J. B.; McIntosh, K.; Zvonic, S.; Garrett, S.; Floyd, Z. E.; Kloster, A.; Di Halvorsen, Y.; Storms, R. W.; Goh, B.; Kilroy, G.; Wu, X.; Gimble, J. M. Immunophenotype of human adipose-derived cells: Temporal changes in stromal- associated and stem cell-associated markers. Stem Cells 24:376-385; 2006.
36. Miyahara, Y.; Nagaya, N.; Kataoka, M.; Yanagawa, B.; Tanaka, K.; Hao, H.; Ishino, K.; Ishida, H.; Shimizu, T.; Kangawa, K.; Sano, S.; Okano, T.; Kitamura, S.; Mori, H. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 12:459-465; 2006.
37. Murohara, T.; Asahara, T.; Silver, M.; Bauters, C.; Masuda, H.; Kalka, C.; Kearney, M.; Chen, D.; Symes, J. F.; Fishman, M. C.; Huang, P. L.; Isner, J. M. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101:2567-2578; 1998.
38. Naito, T.; Ma, L. J.; Yang, H.; Zuo, Y.; Tang, Y.; Han, J. Y.; Kon, V.; Fogo, A. B. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis. Am. J. Physiol. 298:F683-691; 2010.
39. Nambu, M.; Ishihara, M.; Nakamura, S.; Mizuno, H.; Yanagibayashi, S.; Kanatani, Y.; Hattori, H.; Takase, B.; Ishizuka, T.; Kishimoto, S.; Amano, Y.; Yamamoto, N.; Azuma, R.; Kiyosawa, T. Enhanced healing of mitomycin C-treated wounds in rats using inbred adipose tissuederived stromal cells within an atelocollagen matrix. Wound Repair Regen. 15:505-510; 2007.
40. Nash, K.; Hafeez, A.; Hou, S. Hospital-acquired renal insufficiency. Am. J. Kidney Dis. 39:930-936; 2002.
41. Okada, H.; Inoue, T.; Suzuki, H.; Strutz, F.; Neilson, E. G. Epithelial-mesenchymal transformation of renal tubular epithelial cells in vitro and in vivo. Nephrol. Dial. Transplant. 15:44-46; 2000.
42. Planat-Benard, V.; Silvestre, J. S.; Cousin, B.; Andre, M.; Nibbelink, M.; Tamarat, R.; Clergue, M.; Manneville, C.; Saillan-Barreau, C.; Duriez, M.; Tedgui, A.; Levy, B.; Pénicaud, L.; Casteilla, L. Plasticity of human adipose lineage cells toward endothelial cells: Physiological and therapeutic perspectives. Circulation 109:656-663; 2004.
43. Ponte, B.; Felipe, C.; Muriel, A.; Tenorio, M. T.; Liano, F. Long-term functional evolution after an acute kidney injury: A 10-year study. Nephrol. Dial. Transplant. 23:3859-3866; 2008.
44. Rasmusson, I.; Ringden, O.; Sundberg, B.; Le Blanc, K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp. Cell Res. 305:33-41; 2005.
45. Rehman, J.; Traktuev, D.; Li, J.; Merfeld-Clauss, S.; Temm-Grove, C. J.; Bovenkerk, J. E.; Pell, C. L.; Johnstone, B. H.; Considine, R. V.; March, K. L. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109:1292-1298; 2004.
46. Remuzzi, G.; Cattaneo, D.; Perico, N. The aggravating mechanisms of aldosterone on kidney fibrosis. J. Am. Soc. Nephrol. 19:1459-1462; 2008.
47. Rodriguez-Iturbe, B.; Garcia Garcia, G. The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron Clin. Pract. 116:c81-c88; 2010.
48. Satchell, S. C.; Mathieson, P. W. Angiopoietins: Microvascular modulators with potential roles in glomerular pathophysiology. J. Nephrol. 16:168-178; 2003.
49. Schenke-Layland, K.; Strem, B. M.; Jordan, M. C.; Deemedio, M. T.; Hedrick, M. H.; Roos, K. P.; Fraser, J. K.; Maclellan, W. R. Adipose tissue-derived cells improve cardiac function following myocardial infarction. J. Surg. Res. 153:217-223; 2009.
50. Semedo, P.; Correa-Costa, M.; Antonio Cenedeze, M.; Malheiros, D. M. A. C.; Antonia dos Reis, M.; Shimizu, M. H.; Seguro, A. C.; Pacheco-Silva, A.; Camara, N. O. S. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells 27:3063-3073; 2009.
51. Semedo, P.; Palasio, C. G.; Oliveira, C. D.; Feitoza, C. Q.; Goncalves, G. M.; Cenedeze, M. A.; Wang, P. M.; Teixeira, V. P.; Reis, M. A.; Pacheco-Silva, A.; Camara, N. O. S. Early modulation of inflammation by mesenchymal stem cell after acute kidney injury. Int. Immunopharmacol. 9:677-682; 2009.
52. Shin, D. H.; Park, H. M.; Jung, K. A.; Choi, H. G.; Kim, J. A.; Kim, D. D.; Kim, S. G.; Kang, K. W.; Ku, S. K.; Kensler, T. W.; Kwak, M. K. The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis. Free Radic. Biol. Med. 48:1051-1063; 2010.
53. Strutz, F.; Neilson, E. G. New insights into mechanisms of fibrosis in immune renal injury. Springer Semin. Immunopathol. 24:459-476; 2003.
54. Tobita, M.; Uysal, A. C.; Ogawa, R.; Hyakusoku, H.; Mizuno, H. Periodontal tissue regeneration with adiposederived stem cells. Tissue Eng. Part A 14:945-953; 2008.
55. Uccelli, A.; Moretta, L.; Pistoia, V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8:726-736; 2008.
56. Wang, P. H.; Cenedeze, M. A.; Campanholle, G.; Malheiros, D. M.; Torres, H. A.; Pesquero, J. B.; Pacheco-Silva, A.; Camara, N. O. Deletion of bradykinin B1 receptor reduces renal fibrosis. Int. Immunopharmacol. 9:653-657; 2009.
57. Wu, Y.; Deng, J.; Rychahou, P. G.; Qiu, S.; Evers, B. M.; Zhou, B. P. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15:416-428; 2009.
58. Wynn, T. A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214:199-210; 2008.
59. Yagi, H.; Soto-Gutierrez, A.; Parekkadan, B.; Kitagawa, Y.; Tompkins, R. G.; Kobayashi, N.; Yarmush, M. L. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant. 19:667-679; 2010.
60. Zeisberg, M.; Bottiglio, C.; Kumar, N.; Maeshima, Y.; Strutz, F.; Muller, G. A.; Kalluri, R. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am. J. Physiol. 285:F1060-1067; 2003.
61. Zeisberg, M.; Kalluri, R. Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease. Pediatr. Nephrol. 23:1395-1398; 2008.
62. Zeng, R.; Yao, Y.; Han, M.; Zhao, X.; Liu, X. C.; Wei, J.; Luo, Y.; Zhang, J.; Zhou, J.; Wang, S.; Ma, D.; Xu, G. Biliverdin reductase mediates hypoxia-induced EMT via PI3-kinase and Akt. J. Am. Soc. Nephrol. 19:380-387; 2008.
63. Zuk, P. A. The adipose-derived stem cell: Looking back and looking ahead. Mol. Biol. Cell 21:1783-1787. 2010.
64. Zuk, P. A.; Zhu, M.; Ashjian, P.; De Ugarte, D. A.; Huang, J. I.; Mizuno, H.; Alfonso, Z. C.; Fraser, J. K.; Benhaim, P.; Hedrick, M. H. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13:4279-4295; 2002.
65. Zuk, P. A.; Zhu, M.; Mizuno, H.; Huang, J.; Futrell, J. W.; Katz, A. J.; Benhaim, P.; Lorenz, H. P.; Hedrick, M. H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7:211-228; 2001.